Komori
Sysmex (6869) · InitiativeAdvanced

¥25,000 million borrowing for business expansion, ESOP and growth capital

First written in FY2024-Q2. 5 of 8 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2026.

8entries
4years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2024-Q3 – FY2024OtherFY2025-H1 – FY2026-H12023: 120232024: 320242025: 120252026: 32026
Same theme, other companies
Flexible, ongoing financing to meet business operating needs and build a sound financial foundationA theme 194 companies write about · 4 as a headwind · 174 as a tailwind

91 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 194 companies compared. The sentences above are computed from all 194.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Company borrowed funds on 28 April 2026. To meet increased funding needs associated with the expansion of the businesses of consolidated companies, including those in Latin America, and increased shareholder returns, including the acquisition of treasury shares, the Company borrowed a total of ¥50,000 million from multiple banks at a fixed interest rate, for a term of 5 years and without collateral.」

    In addition to the previous ¥25,000 million and other borrowings, executed borrowings totaling ¥50,000 million in April 2026 for business expansion and shareholder returns.
  2. FY2026-H1Updated first-half long-term debt repayment resultsAnnual report

    「Proceeds from long-term borrowings - Repayments of long-term borrowings △356」

    During the interim period of the fiscal year ending September 2025, there were no proceeds from new long-term borrowings, and ¥356 million in repayments of long-term borrowings was recorded.
  3. FY2025-H1Updated first-half long-term borrowing resultsAnnual report

    「This was mainly due to proceeds of ¥3,500 million from long-term borrowings and expenditures of ¥296 million for the repayment of long-term borrowings, among other factors.」

    For the interim period of the fiscal year ending March 2025, disclosed ¥3,500 million in proceeds from long-term borrowings and ¥296 million in repayments of long-term borrowings.
  4. FY2024AdvancedAnnual report

    「This was mainly due to proceeds from long-term borrowings of ¥29,000 million, an increase of ¥29,000 million year on year, dividend payments of ¥17,579 million, an increase of ¥1,050 million, and expenditures for the acquisition of treasury shares of ¥12,001 million, an increase of ¥12,000 million, among other factors.」

    Regarding the borrowing plan for growth funding and other purposes, disclosed execution in the form of ¥29,000 million in proceeds from long-term borrowings.
  5. FY2024-Q3AdvancedAnnual report

    「This was mainly due to proceeds from long-term borrowings of ¥25,000 million, an increase of ¥25,000 million year on year, dividend payments of ¥17,579 million, an increase of ¥1,050 million, and expenditures for the acquisition of treasury shares of ¥12,000 million, an increase of ¥11,998 million, among other factors.」

    Disclosed the execution of the borrowing plan totaling ¥25,000 million announced in the previous quarter, reporting proceeds of ¥25,000 million from long-term borrowings.
  6. FY2024-Q2First statedAnnual report

    「The Company will borrow from financial institutions to fund increases in working capital accompanying business expansion, including in India, acquire the Company's shares in connection with the introduction of a trust-type employee stock ownership plan (ESOP), and meet funding needs for further growth. Total borrowings: ¥25,000 million; interest rate: fixed; term: 5 years; collateral: unsecured.」

    Disclosed a plan, approved by the Board of Directors on 24 October 2023, to borrow a total of ¥25,000 million from multiple banks at a fixed interest rate, for 5 years and without collateral, to fund working capital for business expansion including in India, share acquisitions in connection with the ESOP, and growth funding.
Moved together

"Strengthening the Biochemistry and Immunoassay Testing Portfolio Through the Acquisition of Nippon Denshi's Medical Equipment Business" moved the same way as this thread, in the same document, in 3 of its 8 moves.

332222★123456
  1. ★This thread
  2. 1Strengthening the Biochemistry and Immunoassay Testing Portfolio Through the Acquisition of Nippon Denshi's Medical Equipment Business3×
  3. 2Accelerating the adoption of the fully automated immunoassay system “HISCL”3×
  4. 3Multi-supplier procurement and disaster preparedness and recovery measures at manufacturing sites2×
  5. 4Contributing to a Sustainable Society Through the Resolution of Healthcare Issues and Environmental Action, Governance, and Diversity2×
  6. 5Product Development Value Chain Reform and Improved Profitability2×
  7. 6Creating New Businesses Through Data-Driven Business and Open Innovation2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sysmex yet. It last moved in the General Meetings of Shareholders of 2026-05-29: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
¥25,000 million borrowing for business expansion, ESOP and growth capital | SYSMEX CORPORATION (6869) | Komori